AHA letter urging the Centers for Medicare & Medicaid Services to immediately withdraw the new condition of participation that threatens to expel hospitals from the Medicare program if they fail to comply with “frequently changing and confusing” COVID-19 data collection efforts.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
In a letter to Senator Lamar Alexander and Representative Greg Walden, AHA expresses strong support for the 340B Drug Pricing Program.
As the House Energy and Commerce Committee investigates health insurance company performance during the COVID-1
AHA, others express concern that persistent high COVID-19 rates will continue to stress the entire health care system and urge Congress to pass legislation that would extend the congressionally-enacted moratorium on the application of the Medicare sequester cuts into 2021 and through the duration of the public health emergency (PHE).
AHA again urge the Center for Medicare & Medicaid Innovation to delay the start date for its new radiation oncology alternative payment model until Jan. 1, 2022.
AHA urges CMMI to reconsider sudden changes to the Bundled Payments for Care Improvement Advanced model effective Jan. 1, especially the move to clinical episode service line groups.
AHA comments on the Health Resources and Services Administration’s proposal to add additional counties – specifically, outlying Metropolitan Statistical Area (MSA) counties with no Urbanized Area (UA) – to its list of areas eligible to receive services funded by Federal Office of Rural Health Policy’s rural health grants.
AHA follows up on our previous correspondence on the serious situation Eli Lilly, AstraZeneca and Sanofi are creating for the nation’s most vulnerable communities by refusing to comply with the requirements of the 340B program to sell to contract pharmacies at the discounts required by section 340B of the Public Health Service Act.
As organizations representing nearly 5,000 hospitals and health systems, more than 1 million physicians, and more than 4 million registered nurses, we call on the Trump Administration to rescind Executive Order 13950, Combating Race and Sex Stereotyping. Each of the actions outlined in EO 13950 would effectively reverse decades of progress in combating racial inequality.
AHA Comments on Developing a SNF Healthcare-Associated Infections Requiring Hospitalizations Measure
The AHA appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services Healthcare-Associated Infections (HAIs) Requiring Hospitalizations Measure.